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Protein kinase C activity of the human myeloma cell line, RPM1 8226, was studied after prepurification on DEAE-cellulose. The total protein 
kinase activity, eluted at 0.12 M NaCl, was 493 nmol/min/lpO cells, but 38% was associated with membranes. The lipid dependence of cytosolic 
and membrane activities was only 52% and 211, respectively. This activity increased with time, to as much as 2ooqb for the membrane fraction 
after 7 days, whereas lipid dependence and the PDBu bin~ng proper&& were lost. This modified activity was not due to the extinction of a copurify- 
ing endogenous inhibitor nor to classical PKC proteolysis. TPA-treatment of these eels is accompanied by a rapid, selective and complete loss 
of lipid-dependent activity of the cytosol, thus benefiting co-migrating lipid independent activity, with no membrane fraction recovery or PKM 
formation. 
Myeloma cell line; RPM1 8226; B lymphocyte; protein kinase C 
1. INTRODUCTION 2. MATERIALS AND METHODS 
PKC, a closely related protein kinase family, is one of 
the major regulatory enzymes implicated in the 
transmission of extracellular signals into the cells. It 
plays pivotal roles in cell proliferation and differentia- 
tion, although the key target substrates have not yet 
been identified. Its identification as the major cellular 
receptor for tumor promoting phorbol esters also 
points to its involvement in tumorigenesis, and many 
efforts have currently been directed towards inter- 
preting this role (I-31. Cells altered by a variety of on- 
cogenes show modifications which lead to persistent 
PKC activation [3-51. Cellular overexpression of nor- 
mal PKC species [6,7] results in altered growth regula- 
tion and induces oncogenicity as observed by mutation 
[8] or phorbol-ester treatment [l-3]. We recently show- 
ed that PKC function was indispensible for triggering 
L2C guinea pig leukemic B lymphocyte proliferation 
191. In this study, we observed quite abnormal behavior 
of PKC activity in the human myeloma cell line RPM1 
8226. 
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2.1. Chemicals and biological materials 
[T-~~P]ATP and [‘H]PDBu were from Amersham and NEN respec- 
tively. L-cY-phosphatidylserine, 1 2_dioieoyl-sn-glycerol and histone 
Hl type 111s were from Sigma. The Epstein-Barr virus-negative 
RPM1 8226 cell line has lymphoplasmocyte cells phenotype and is a 
model of myeloma tumor stem cells [IO). Cells were grown in RPM1 
1640 (Boehringer Mannheim) supplemented with 1 mM glutamine, 50 
$vl &mercaptoethanol and 10% fetal calf serum. Cultures were in- 
cubated at 37OC in a 5% Ca humidified incubator. 
2.2. Preparation of cytosolic and particulate fractions 
In standard conditions, 1-2 108 cells were suspended in 10 ml of 
buffer A at 4°C (20 mM Tris-HCI, pH 7.5, 300 mM sucrose, 2 mM 
EDTA, 10 mM EGTA, 2 mM di~iothreitol, 2 mM phenylmethyl- 
sulfonyl fluoride, 50 &ml of leupeptin and E64). Unbroken cells 
were removed by centrifugation at 1000 x g and the homogenate was 
centrifuge for 30 min at 100000 x g. The supernatant (cytosolic 
fraction) was kept at 4’C whereas the pellet (membrane fraction) was 
resuspended for 1 h in 10 ml of buffer A containing 0.5% Triton 
X-100. The extracts were then adsorbed onto 5 ml of DE-52 ion ex- 
change cellulose (Whatm~) for 30 min before inst~lation of the resin 
in cotumns connected to an FPLC apparatus (Pharmacia), and 
equilibrated with buffer B (20 mM Tris-HCl, pH 7.5, 2 mM EDTA 
and EGTA, 1 mM dithiothreitol). Columns were washed through 
with 4 volumes of the ~uilibration buffer before elution as indicated 
in the text. Aliquots of each fraction were then assayed for PKC (30 
d) or PDBu binding (20 &. In some experiments, protein kinase C 
from rat brain was obtained after partial purgation on DE-52 [I I]. 
Its activity was more than 90% dependent on lipids. 
2.3. Determination of proIein kinase C 
Assays were performed using 500 &ml of histone Hl, type III S 
as the substrate and 50 CM [~-32P]ATP (100-250 dpm/pmol) in 
96-multiwell dishes [l I]. When indicated, activities were calculated 
from the difference in 32P incorporated into histone in the presence 
and absence of added phosphatidyl~rine, diolein. and Ca2 + (replaced 
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by 0.5 mM EGTA). Each unit of protein kinase activity corresponds 
to 1 nmol of phosphate transferred to histone Hl/min at 25°C. 
t3H]PDBu binding was measured with mixed micelles of Triton X-100 
containing 0.3% Triton X-100 and 0.6 mg/ml of phosphatidylserine 
and 50 nM [‘HIPDBU (20.8 Ci/mmol). Non-specific binding was 
determined by adding a 7.5 FM excess of unlabelled PDBu. The 
bound [3H]PDBu was separated from the free ligand after absorption 
ot DEAE-Sephacel [ 111. 
3. RESULTS 
Prior to the experiment, cells were maintained for 3 
days in complete medium, and then the medium was 
removed and cells incubated for 24 h in a fresh medium 
at a cell density of 8-10 lo6 cells/ml. This refreshment 
procedure seems to provide the best experimental con- 
ditions for comparing protein kinase activities. 
PKC activity of cytosol and particulate fractions of 
RPM1 8226 cells was determined after prepurification 
on DEAE-cellulose columns. The elution showed 2 
peaks of kinase activity in the cytosol (Fig. 1). The first 
peak (peak I) which eluted off the column at around 
0.15 mM NaCl, bound [‘H]PDBu, but showed partial 
dependence on PS and Ca*+ for activity. The second 
peak (peak II) appeared entirely independent of the ad- 
dition of lipids and Ca* + . Characterization of this sec- 
ond peak revealed the absence of c-AMP dependent 
protein kinase. We tried to use a discontinuous gradient 
in the DE-52 elution. The elution profile using two ma- 
jor NaCl concentrations i.e. 0.14 M and 0.35 M suc- 
cessively, revealed two kinase activity peaks, with 
distribution and lipid dependence in agreement with the 
continuous gradient profile shown in Fig. 1. The total 
kinase activity, its distribution between peak I and peak 
II, and the lipid-dependence characteristics, were quite 
similar when the NaCl concentration, at the first step of 
the discontinuous gradient, was 0.12, 0.14 or 0.17 M. 
This demonstates the great difference and the clear divi- 
sion between the two activities. Similar elution profiles 
were obtained for the membrane extracts (not shown), 
except that the total activity and the lipid dependence 
were lower (see below). 
Surprisingly, we observed an increase in protein 
kinase activity when measured at various times after 
elution. This increase seems to be restricted to peak I 
(Fig. 2), which was better illustrated over an 8-day 
period (insert). The increase was considerably high for 
membranes, the activity was 140 and 420 pmoles/lO’ 
cells at days 0 and 7 respectively, i.e. a 200% increase. 
In the same experiment, the activity of peak I of cytosol 
was 288 pmol of PKC/lO’ cells after elution but reach- 
ed 426 pmol PKC/lO’ cells 7 days later. This was 
associated with a complete loss of lipid dependance, 
and PDBu binding properties. Thus, in the above ex- 
periment, activity of peak I from cytosolic and mem- 
brane fractions was originally dependent on lipids, 42% 
and 26% respectively, whereas this lipid dependence 
considerably decreased at day 2, and no longer existed 
at day 4. 
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Fig. 1. DEAE-cellulose chromatographic analysis of the cytosolic 
protein kinase activities. Extract from 1.5 x 10’ cells was applied to 
DE-52 columns (1.1 x 5 cm). The column was eluted with 40 ml of 
a O-425 mM NaCI linear gradient in buffer B at a flow rate of 1 
ml/min. Aliquots of each fraction were tested for protein kinase 
activity in the precence (m ) or the absence of lipids and calcium ( q ) 
and PDBu binding (x). The non-specific binding was less than 200 
dpm/20 ~1 fractions. Dotted lines refer to the NaCl concentration. 
Protein kinase activities are expressed as dpm of 32P incorporated into 
histone H1/5 mitt/30 ~1 ahquot. 
It was also intriguing to note that with the dilution of 
peak I extracts, there was a much higher kinase activity 
than in the original sample. Thus, a 6-fold dilution with 
buffer B containing 0.14 M NaCl led to an increase of 
110% and 50% of total cytosol and membrane extract 
activity respectively. 
The temporal evolution of protein kinase activity in 
RPM1 8226 cells and its differential expression as a 
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Fig. 2. Temporal evolution of the protein kinase activities. The 
membrane extracts of 1.5 x ld cells were fractionated on DE-52 
columns as in Fig. 1A. Protein kinase activities were assayed 
immediately (e), or after 48 h (x). Inserts show the total (0) and the 
lipid-insensitive (0) activity recovered in peak I over g-day periods, 
while keeping the various fractions at 4OC. 
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function of its concentration in the medium made quan- 
tification difficult and somewhat imprecise. This led us 
to choose strictly defined conditions (Table I). Total 
histone H-l kinase activity eluting at 0.14 M from 
cytosol and membrane fraction was 303 + 28 and 190 
f 20 units/cells, indicating that 38 + 2% of their total 
activity was in the membranes. Lipid and Ca’ + 
dependence of the cytosolic and membrane fractions 
was significantly different at 52 f 6 and 21 + 2% 
respectively. A similar kinase activity was eluted at 0.35 
M NaCl for each of the fractions, but the activity seem- 
ed to be entirely independent of the addition of lipids 
and Ca* + . Only peak I could bind (3H) PDBu, with 
values ranging from 1.85 f 0.12 (n= 7) and 0.59 f 
0.05 (n= 6) pmol/unit of protein kinase activity for 
cytosolic and membrane fractions respectively. 
The above reported activity increase for peak I could 
be due either to a modification of the enzyme itself or 
to the extinction of the action of a coeluted-endogenous 
inhibitor. In this context, we studied the effect of peak 
I fractions on the expression of a known amount of rat 
brain PKC. The DE-52 extract from the RPM1 8226 
membrane fraction, from fraction 20, produced a 
significant inhibition of brain PKC. However, this in- 
hibition did not coincide with fractions showing in- 
creased kinase activity, as illustrated in Fig. 3. Thus, 
fraction 15 tripled its activity after 24 h, but did not 
contain any inhibitor acting on rat brain PKC. In the 
same way, the DE-52 extract of the RPM1 8226 cytosol 
eluting beyond fraction 15 produced a significant in- 
hibition of rat brain PKC (maximum inhibition of 50% 
with fraction 21-24). But, here also, this inhibition did 
not coincide with fractions showing increased kinase ac- 
tivity (not shown). When tested 4 days after collection, 
the DE-52 eluate from the cytosolic and membrane 
fraction of RPM1 8226 showed a similar inhibition pro- 
file, except for a slightly lower amplitude, of rat brain 
PKC (not shown). 
Table I 
Protein kinase activities in cytosolic and membrane fractions of 
RPM1 8226 cells 
Cytosol Membrane % in membrane 
Eluted at 0.14 M NaCl 
+PL 303 f 28 190 f 20 38 f 2% 
-PL 172 f 14 155 f 20 45 f 4% 
(PL)d 132 f 26 39 f 8 24 f 6% 
% (PL)d 52 f 6% 21 f 2% 
Eluted at 0.35 M NaCl 
+PL 262 f 29 183 f 32 40 f 3% 
-PL 248 f 30 195 f 28 43 f 5% 
% (PL)d 4% 0% 
Extract from 1.5 to 2 x 10s cells were fractionated on DEAE- 
cellulose with a discontinuous gradient of NaCl. The protein kinase 
eluted at 0.14 M and 0.35 M were tested in the presence (+ PL) or 
absence (- PL) of lipids. (PL)d indicates protein kinase activity that 
was lipid-dependent. Activities are expressed as nmol/lO’O cells/min 
and are means f SE of 8 experiments with different batches of cells. 
Fraction No (lml) 
Fig. 3. Effect of the DE-52 eluate of membrane fractions on rat brain 
protein kinase C. The membrane fraction of 1.5 x lo8 cells was 
fractionated on DE-52 columns as in Fig. 1. Aliquots containing 15 ~1 
of each fraction RPM1 8226 cells plus 15 ~1 of partially purified rat 
brain PKC (representing 85 000 f 3000 dpm) were assayed for activity 
(0). The expressed protein kinase activity is the one observed minus 
the endogenous activity due to the RPM1 8226 extract (highest 
endogenous activity was observed in fraction No13 with 7000 dpm). 
The lipid independent part of the brain kinase activity was not 
changed by the addition of RPM1 8226 cell extract, and remained 
below 7500 dpm. The percentage increase of the endogenous activity 
of RPM1 8226 extract after 48 h, as observed in Fig. 2, is 
simultaneously shown (0) and does not correspond to the inhibition of 
brain PKC. 
It was intriguing that the protein kinase activity 
eluted at 0.14 M NaCl was partly independent of PS 
and Ca*+. Protein kinase M, a protease-activated form 
of PKC which is liberated from the lipid and Ca2+ to 
exert its enzymatic activity [ 121, could be involved in 
lipid-insensitive kinase activity, and in the loss of this 
dependence as a function of time. Thus, we looked for 
such a transformation by rechromatographying the 
peak eluting at 0.14 M on DE-52 columns, two days 
after the original elution. In a typical experiment, 
although lipid dependence had almost completely 
disappeared, and all activity had greatly increased, the 
kinase activity was recovered at only 0.14 M. The 
eventually formed PKM, which is normally eluted at 
0.35 M NaCl [ 12,131 was less than twice the radioactive 
background, and less than 5% of the total activity. It 
should be noted that the recovery of total activity 
(calculated in terms of the whole peak at day + 2), was 
90% for the cytosolic fraction, but rather poor (43%) 
for the membrane fraction. The proteolysis of PKC and 
transformation into PKM during the test period when 
Ca* + and PL are present is another possible explana- 
tion for partial lipid dependence. In this context, the 
fractions composing peak I were incubated in condi- 
tions exactly similar to those used for PKC determina- 
tion, with histone, for 10 min at 37”C, before carrying 
out a new DE-52 chromatography. For both the 
cytosolic and the membrane fraction, the activity 
recovered at 0.35 M NaCl was less than 5% of total ac- 
tivity. In fact, all the activity was eluted at a 0.14 M 
333 
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Fig. 4. Effect of TPA on the 0.14 M eluted protein kinase activity. 
RPM1 8226 cells were incubated in fresh medium at lo6 cells/ml and 
then treated with 162 nM TPA for the indicated times before pelleting 
the cells and separation of the cytosolic (A) and membrane fractions 
(B). After prepurification on DE-52 columns, protein kinase activity 
was assayed in the presence (full bar) or the absence (black bar) of 
lipids and Ca ‘+ The hatched bar represents the lipid-dependent . 
protein kinase activity. 
NaCl concentration. The kinase activity recovery was 
67% and 26% for the cytosol and membrane fraction 
respectively. In this case, the lipid dependence of peak 
I was not significantly modified by the second ion ex- 
change chromatography. 
Finally, we studied the effect of 162 nM TPA on 
levels and distribution of 0.14 M eluted protein kinase 
activity (Fig. 4). Surprisingly, TPA treatment does not 
clearly change total kinase activity levels of the cells. 
However, it was quite obvious that TPA treatment 
selectively modified lipid dependence of the cytosolic 
kinase activity. This lipid dependence was originally 
63%) but dropped to 6% and 0% after 5 and 15 min 
TPA treatment respectively. This was due to an increase 
in the lipid-independent part of kinase activity. Over 15 
min, lipid dependence quickly and partially recovered 
to 32% after 120 min treatment. On the other hand, the 
total activity, and the lipid dependence did not seem to 
be altered in the membrane fraction. The kinase activity 
eluted at 0.35 M did not show any significant variation 
in the presence of TPA (not shown). 
4. DISCUSSION 
Almost all of the kinase activity in normal lym- 
phocytes is recovered in the cytosolic fraction while 
translocation to the membrane compartment occurs 
after stimulation, which constitutes an index of in situ 
activation of the enzyme [1,2,9]. PKC activity from 
RPM1 8226 cells was eluted from DEAE cellulose at 
0.12 M NaCl as can be observed in a large number of 
other cells. The total amount of PKC activity is similar 
with B lymphocytes of different species at different 
stages but there is a clarly marked appearance of PKC 
in the membrane fraction (Table I). 
There was a conspicuous, only partial dependence of 
lipids for the expression of PKC activity. PKC can be 
converted, by different types of proteases which are 
probably of physiological importance, to a form which 
no longer requires PL for activation [1,2, lo]. The ac- 
tion of calpain is quite fulgurant [14]. However, such 
conventional degradation, either in the eluate of the 
DE-52 column or in the assay mixture is clearly exclud- 
ed since rechromatography of the activity after cor- 
responding incubation gave the same elution profile 
and lipid-dependence as previously observed, without 
any significant appearance of PKM. 
There is a possible presence of endogenous activators 
which could co-purify, and be responsible for the par- 
tial lipid dependence. Thus, after activation of the 
whole cells by TPA, the recovered enzyme behaved as a 
membrane constituent, and could not be freed of PL 
and TPA during the subsequent chromatographic 
analyses on the DEAE sephacel column [15]. However, 
it is remarkable that the possible endogenous activator 
has no effect on rat brain PKC (Fig. 3). (The presence 
of an extremely tight complex with an activator, 
without possible exchangeability, can be hypothesized.) 
The evolution of the total activity, the loss of PL 
dependence and the PDBu-binding properties of the 
0.14 M eluted activity was surprizing. This suggests the 
interconversion of a lipid-dependent into a lipid- 
independent activity, and could reflect conformational 
changes of the enzyme, or the presence of effecters. 
However, this temporally increased activity is probably 
not due to the inactivation of an endogenous conven- 
tional inhibitor, otherwise it would have the same effect 
on rat brain PKC. These facts, and the increased activi- 
ty after dilution of the samples, illustrate the problems 
in describing activities, since the proportions in mem- 
branes are much higher if ulterior activities are con- 
sidered. 
Activation of the intracellular PKC by phorbol esters 
lead to translocation of the cytosolic form to the mem- 
brane, as observed in many different cell types. This 
recruitment is usually followed by a protease-mediated 
transformation of PKC into PKM, which does not con- 
tain the hydrophobic domain required for association 
with the membrane [1,12,15]. The temporal effect of 
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TPA on RPM1 8226 showed a rapid and complete 
depletion of cytosolic-dependent activity with no quan- 
titative recovery of the activity in the membrane frac- 
tion. More intriguing is the fact that the loss of lipid 
dependence is not associated with the formation of the 
0.35 M migrating PKM, but is associated with an in- 
crease of co-migrating lipid-independent protein kinase 
activity. No explanation can be given at present, but 
this reveals the atypical behavior of protein kinase C in 
these cells. One possibility would be that the mem- 
brane, saturated with the enzyme, cannot support any 
additional enzyme. 
Alterations in cell growth and differentiation are 
reflected by differences in PKC subcellular distribution 
whereas activation of PKC as reflected by translocation 
of the enzyme from the cytosol to the membrane frac- 
tion has been firmly associated to its role in such 
cellular functions as cell proliferation, viral transforma- 
tion and leukemia cell differentiation [l-3,16,17]. The 
subcellular localization (rather than the total level of 
PKC) seems markedly altered in transformed cells, 
probably due to translocation, activation, and down 
regulation [l, 161. More recently, an unusual PKC 
subcellular distribution, largely membranar, was 
observed in a fibrosarcoma cell line whose PKC share 4 
point mutations, three of them being located in the 
highly conserved regulatory domain [S]. It is also 
remarkable that, when the data are available, the lipid- 
insensitive part of the protein kinase C activity increases 
in many transformed cells [e.g. 181. 
Since neoplastically transformed cells differ from 
non-transformed cells in parameters related to 
unrestrained growth, the question could be raised as to 
whether changes in PKC are generally related to growth 
rather than specifically to transformation. Our results 
do not necessarily indicate the direct interaction of 
unknown activators, nor exclude the possibility that 
protein kinase has atypical properties. In the former 
case, a specific lipid-protein interaction would pres- 
umably be needed for the activation of PKC. 
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